MedTrace Logo

Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial

NCT03045276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 465

Last updated 2023-11-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplant (KT) or spina bifida (SB).

Conditions

  • Spina Bifida
  • Kidney Transplant

Interventions

BEHAVIORAL

Behavioral Feedback and Economic Incentives: Arm 1

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplants (KT) or spina bifida (SB). In Arm 1, participants will not receive personalized feedback, nor will they receive the "extra" incentive of $10 for meeting their adherence goal.

BEHAVIORAL

Behavioral Feedback and Economic Incentives: Arm 2

The purpose of this study is to determine the effectiveness of behavioral feedback plus economic incentives to promote treatment adherence among a large diverse population of adolescents and young adults (AYA) with kidney transplants (KT) or spina bifida (SB). In Arm 2, participants will receive personalized feedback, and an "extra" incentive of $10 for meeting their adherence goal.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Boston Children's Hospital

    collaborator OTHER

  • Children's Healthcare of Atlanta

    collaborator OTHER

  • Children's Mercy Hospital Kansas City

    collaborator OTHER

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • Seattle Children's Hospital

    collaborator OTHER

  • Children's Hospital of Philadelphia

    lead OTHER

Principal Investigators

  • Sandra Amaral, MD, MHS · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-29
Primary Completion
2022-04-09
Completion
2022-04-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045276 on ClinicalTrials.gov